Webb spots outsized early black hole & GSK hepatitis B drug boosts cures - News (May 29, 2026)

CAR-T clears path for transplants & AI-designed coronavirus vaccine tested - News (Jun 5, 2026)

Please support this podcast by checking out our sponsors: - Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron [https://www.stock-mvp.com/?via=ron] - Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad [https://try.elevenlabs.io/tad] - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily [https://get.consensus.app/automated_daily] Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily [https://buymeacoffee.com/theautomateddaily] TODAY'S TOPICS: CAR-T CLEARS PATH FOR TRANSPLANTS - ENGINEERED CAR-T CELLS HELPED HIGHLY SENSITIZED KIDNEY PATIENTS RECEIVE TRANSPLANTS BY REDUCING ANTIBODY-DRIVEN REJECTION RISK, POTENTIALLY EXPANDING ACCESS BEYOND DIALYSIS. AI-DESIGNED CORONAVIRUS VACCINE TESTED - CAMBRIDGE RESEARCHERS TESTED AN AI-DESIGNED “SUPER-ANTIGEN” CORONAVIRUS VACCINE CONCEPT IN HUMANS, AIMING FOR BROAD PROTECTION AGAINST FUTURE VARIANTS AND SPILLOVERS. GLP-1 DRUGS AND CANCER SIGNALS - ASCO-PRESENTED STUDIES SUGGEST GLP-1 MEDICINES MAY CORRELATE WITH LOWER CANCER RISK AND IMPROVED OUTCOMES, PROMPTING CALLS FOR RANDOMIZED CLINICAL TRIALS AND CAREFUL SAFETY REVIEW. LENACAPAVIR INJECTION FOR HIV PREVENTION - SOUTH AFRICA IS ROLLING OUT TWICE-YEARLY LENACAPAVIR FOR HIV PREVENTION, A LONG-ACTING PREP OPTION THAT COULD BOOST ADHERENCE AND REDUCE NEW INFECTIONS. EU PUSHES TECH SOVEREIGNTY LAWS - THE EUROPEAN COMMISSION PROPOSED A TECHNOLOGICAL SOVEREIGNTY PACKAGE COVERING CHIPS, CLOUD, AI, AND OPEN SOURCE TO REDUCE DEPENDENCE ON NON-EU SUPPLIERS AND SECURE CRITICAL SERVICES. CANADA’S AI PLAN AND SOVEREIGNTY - CANADA’S NATIONAL AI STRATEGY INCLUDES BILLIONS FOR AI LITERACY, DOMESTIC COMPUTING CAPACITY, AND TALENT RETENTION, WHILE CRITICS SAY SAFETY AND ONLINE PROTECTIONS ARE STILL VAGUE. US–JAPAN AI RESEARCH PARTNERSHIP - JAPAN AND THE US LAUNCHED A $1 BILLION INITIATIVE TO SPEED R&D USING AI, INCLUDING AUTONOMOUS LABS FOR QUANTUM, FUSION, AND BIOTECH, WITH AN EYE ON STRATEGIC COMPETITION. SELF-REPLICATING AI WORM RAISES ALARMS - UNIVERSITY OF TORONTO RESEARCHERS DEMONSTRATED A PROOF-OF-CONCEPT SELF-REPLICATING “AI WORM” THAT ADAPTS EXPLOITS USING A LOCAL LANGUAGE MODEL, HIGHLIGHTING NEW CYBER DEFENSE NEEDS. GOOGLE SEEKS STERILE MOSQUITO RELEASE - GOOGLE ASKED US REGULATORS TO ALLOW LARGE-SCALE RELEASES OF STERILIZED MALE MOSQUITOES CARRYING WOLBACHIA TO REDUCE DISEASE VECTORS, TESTING PUBLIC ACCEPTANCE OF BIOLOGICAL CONTROL. LARGEST COSMIC MAGNETIC FIELD MAP - CSIRO AND SKA OBSERVATORY PARTNERS RELEASED SPICE-RACS, THE BIGGEST MAGNETIC-FIELD MAP OF THE UNIVERSE, ENABLING NEW STUDIES OF GALAXY EVOLUTION AND THE COSMIC WEB. Episode Transcript CAR-T clears path for transplants Let’s start with the medical story that could reshape organ transplantation for a very specific, very vulnerable group of patients. Two independent teams, writing in the New England Journal of Medicine, report that three people with end-stage kidney disease successfully received kidney transplants after a single treatment with engineered CAR-T immune cells. These patients were considered “highly sensitized,” meaning their immune systems carried high levels of antibodies that typically trigger rapid rejection—so high that compatible donors were effectively out of reach and dialysis was the only realistic option. More than a year later, the transplanted kidneys are still functioning, and the clinicians reported no notable side effects in these cases. The key idea is to use a patient’s own modified immune cells to dial down the specific antibody-producing cells that drive rejection risk. It’s early, and it’s only a few patients—but if larger studies confirm this, it could open transplant access for people who’ve been shut out by biology, not by a shortage of donors alone. AI-designed coronavirus vaccine tested Staying in health, researchers at the University of Cambridge say they’ve tested a fundamentally new vaccine concept in humans—one where the central antigen was designed entirely by artificial intelligence. Instead of aiming at one circulating strain, the AI looked across genetic sequences from many coronaviruses and designed a sort of “super-antigen” intended to train immunity across the whole family, including potential future animal-to-human spillovers. In a small early trial of 39 people, the focus was safety, and the immune response was described as modest. Still, the team argues the approach is promising enough to justify a bigger follow-up study of about 200 participants. The bigger idea here is preparedness: if vaccines can be designed to cover broader viral families, the world may not have to play catch-up as often when viruses mutate or jump species. GLP-1 drugs and cancer signals More provocative signals in medicine came out of the American Society of Clinical Oncology meeting, where researchers discussed a growing body of evidence around GLP-1 drugs—best known for diabetes and weight loss—and cancer outcomes. Across more than two dozen mostly observational studies using health records and real-world databases, GLP-1 users appeared to have lower risks for certain cancers and, in some analyses, better outcomes like reduced metastasis and improved survival. One large study in women linked GLP-1 use with a markedly lower breast cancer risk; another found lower odds of metastatic spread in several cancers. Researchers suspect the story could involve inflammation and metabolic effects, not just weight loss. But the caution is just as important: observational signals can be misleading, shaped by differences in who gets these medications and what care they can access. The takeaway is momentum—these patterns are consistent enough that experts are calling for randomized clinical trials to test whether GLP-1s can actually help prevent cancer or improve treatment results. Lenacapavir injection for HIV prevention And in HIV prevention, South Africa is marking a major milestone with the rollout of Lenacapavir, a long-acting injection designed to prevent infection with just two doses a year. President Cyril Ramaphosa is set to officially launch the programme in Secunda, alongside health leaders and international partners. The significance is practical: daily prevention pills work well, but adherence is hard in the real world. A twice-yearly option could widen access and make consistent protection more realistic for more people—especially in a country running the world’s largest HIV treatment programme, where preventing new infections remains essential to ultimately ending the epidemic. EU pushes tech sovereignty laws Now to policy and power: the European Commission has unveiled what it’s calling a European Technological Sovereignty Package, aimed at boosting Europe’s ability to build and control key digital technologies. The plan spans chips, artificial intelligence, cloud computing, and open source software, and it reflects a simple pressure point: rising AI-driven demand for computing, paired with heavy reliance on non-EU suppliers. The Commission’s argument is that reducing these dependencies isn’t just about industry—it’s about resilience for critical services like healthcare systems, energy grids, and digital public services. Whether the package delivers will depend on funding, execution, and how quickly Europe can translate ambition into capacity. Canada’s AI plan and sovereignty Canada is also pushing the idea of “AI sovereignty,” unveiling a national AI strategy for the next decade. Prime Minister Mark Carney framed AI adoption as inevitable and put more than two billion Canadian dollars on the table for AI literacy and faster uptake across business and government. Ottawa wants to build domestic computing muscle, including a secure public supercomputer and more Canadian data centres by 2030, while also trying to slow the talent drain with research funding, university positions, and faster immigration pathways for skilled workers. The plan emphasizes practical areas like healthcare, with money earmarked to cut administrative load and improve diagnostics. The political friction point: critics say the strategy is light on concrete details for AI safety and online protections—exactly the area where public anxiety is highest. US–Japan AI research partnership On the international stage, Japan and the United States announced a five-year, one-billion-dollar joint initiative to accelerate research using AI, with each country contributing half. Japan becomes the first international partner in the US “Genesis Mission” programme, and the collaboration is aimed at advanced fields like quantum technology, nuclear fusion, and biotechnology. A headline element is the push toward AI- and robotics-enabled labs—facilities that can run parts of the research process more continuously and systematically. Beyond the science, there’s geopolitics: officials framed it as a way to maintain a technological edge, with China clearly in the background of that conversation. Self-replicating AI worm raises alarms Now, a story that will make security teams sit up straighter. Researchers at the University of Toronto’s CleverHans Lab say they’ve built a proof-of-concept self-replicating “AI worm” that uses an open-weight language model to adapt as it moves through a network—rather than relying on a fixed, pre-planned playbook. In tests run in an isolated environment, the worm was able to identify vulnerabilities, gain higher levels of access, and spread widely. What’s especially unsettling is the economics: because the model can run locally on compromised machines, it may bypass the kinds of guardrails people associate with hosted AI services, and it can essentially use victims’ computing power to keep going. The researchers say they won’t publicly release the tool, and they’re urging defenses like tighter network segmentation and zero-trust approaches. The larger point is that AI isn’t only speeding up defenders—it can also compress the cost and time required for attackers. Google seeks sterile mosquito release In public health and environmental intervention, Google has asked US regulators for permission to release up to 32 million sterilized mosquitoes in parts of California and Florida over two years. The idea is to reduce populations of disease-carrying mosquitoes using a technique that aims to prevent viable offspring, focusing on male mosquitoes—which don’t bite—while targeting the broader population decline over time. Experts note the method is used in pest management, but scaling it up is hard: mass-producing, transporting, and releasing fragile insects safely is a real logistical challenge. This request is also a test case for oversight and public trust, as private-sector involvement in biological control becomes more visible. Largest cosmic magnetic field map Finally, a quick look up—way up. An international team led by Australia’s CSIRO and the SKA Observatory has released SPICE-RACS, described as the largest map yet of the universe’s magnetic fields, and about five times larger than previous efforts combined. Built using the ASKAP radio telescope in Western Australia, the project tracks how radio waves from distant galaxies are subtly twisted by magnetic fields along their path. The result is a dataset covering millions of galaxies, now publicly available, that scientists say will sharpen research into how magnetic fields influence galaxy growth and the movement of matter through space—including in and around our own Milky Way. It’s one of those infrastructure-like science releases: not a single “answer,” but a tool that can unlock many new questions. Subscribe to edition specific feeds: - Space news * Apple Podcast English [https://apple.co/4cLLrdt] * Spotify English [https://spoti.fi/4jN8Dui] * RSS English [https://bit.ly/the_automated_daily_space] Spanish [https://theautomateddaily.com/space_es/feed.xml] French [https://theautomateddaily.com/space_fr/feed.xml] - Top news * Apple Podcast English [https://apple.co/3PTvdUF] Spanish [https://apple.co/3ECCMgk] French [https://apple.co/4hmcxbB] * Spotify English [https://spoti.fi/3ZYXAW2] Spanish [https://spoti.fi/414h4JD] French [https://spoti.fi/3Di0jDe] * RSS English [https://bit.ly/the_automated_daily_news] Spanish [https://bit.ly/the_automated_daily_news_es] French [https://bit.ly/the_automated_daily_news_fr] - Tech news * Apple Podcast English [https://apple.co/3RYWbg4] Spanish [https://apple.co/4i0WqRM] French [https://apple.co/4bEAXMm] * Spotify English [https://spoti.fi/3S089pG] Spanish [https://spoti.fi/3EE2Fwv] Spanish [https://spoti.fi/3DlObRE] * RSS English [https://bit.ly/the_automated_daily_tech] Spanish [https://bit.ly/the_automated_daily_tech_es] French [https://bit.ly/the_automated_daily_tech_fr] - Hacker news * Apple Podcast English [https://apple.co/48QWyzj] Spanish [https://apple.co/4ke9jtE] French [https://apple.co/41E1qFd] * Spotify English [https://spoti.fi/45zD1kf] Spanish [https://spoti.fi/4hF8h81] French [https://spoti.fi/3QY26Ak] * RSS English [https://bit.ly/the_automated_daily_hacker_news] Spanish [https://bit.ly/the_automated_daily_hacker_news_es] French [https://bit.ly/the_automated_daily_hacker_news_fr] - AI news * Apple Podcast English [https://apple.co/3M6Tg1o] Spanish [https://apple.co/4315L7Y] French [https://apple.co/3DkZbPb] * Spotify English [https://spoti.fi/3tzOfrz] Spanish [https://spoti.fi/416m40q] French [https://spoti.fi/41HuJGW] * RSS English [https://bit.ly/the_automated_daily_hackernews_ai] Spanish [https://bit.ly/the_automated_daily_hackernews_es_ai] French [https://bit.ly/the_automated_daily_hackernews_fr_ai] Visit our website at https://theautomateddaily.com/ [ https://theautomateddaily.com/] Send feedback to feedback@theautomateddaily.com Youtube [https://www.youtube.com/@TheAutomatedDaily] LinkedIn [https://www.linkedin.com/in/the-automated-daily/] X (Twitter) [https://x.com/automated_daily]

Self-adapting AI worm cyber risk & Europe’s push for tech sovereignty - News (Jun 4, 2026)

Please support this podcast by checking out our sponsors: - Lindy is your ultimate AI assistant that proactively manages your inbox - https://try.lindy.ai/tad [https://try.lindy.ai/tad] - KrispCall: Agentic Cloud Telephony - https://try.krispcall.com/tad [https://try.krispcall.com/tad] - Prezi: Create AI presentations fast - https://try.prezi.com/automated_daily [https://try.prezi.com/automated_daily] Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily [https://buymeacoffee.com/theautomateddaily] TODAY'S TOPICS: SELF-ADAPTING AI WORM CYBER RISK - UNIVERSITY OF TORONTO RESEARCHERS DEMONSTRATED A PROOF-OF-CONCEPT “AI WORM” USING OPEN-WEIGHT MODELS THAT CAN ADAPT ATTACKS IN REAL TIME, RAISING NEW CYBERSECURITY AND CRITICAL-INFRASTRUCTURE CONCERNS. EUROPE’S PUSH FOR TECH SOVEREIGNTY - THE EUROPEAN COMMISSION UNVEILED A TECHNOLOGICAL SOVEREIGNTY PACKAGE, INCLUDING CHIPS ACT 2.0 AND A CLOUD AND AI DEVELOPMENT ACT, AIMING TO REDUCE EU DEPENDENCE ON NON-EU SEMICONDUCTORS, CLOUD, AND AI SUPPLIERS. GOOGLE AI OVERVIEWS AND PUBLISHERS - THE UK CMA WILL REQUIRE GOOGLE TO LET PUBLISHERS OPT OUT OF AI OVERVIEWS AND TO ADD CLEARER ATTRIBUTION, A MOVE TIED TO TRAFFIC, CONTENT PAYMENTS, AND THE FUTURE ECONOMICS OF ONLINE JOURNALISM. MATH COMMUNITY’S AI WARNING - THE LEIDEN DECLARATION ON ARTIFICIAL INTELLIGENCE AND MATHEMATICS WARNS THAT AI-GENERATED BUT INCORRECT PROOFS, WEAK TRANSPARENCY, AND CORPORATE HYPE COULD POLLUTE THE RESEARCH RECORD AND DISTORT CREDIT AND INCENTIVES. MICROSOFT’S MAJORANA 2 QUANTUM CLAIM - MICROSOFT SAYS ITS MAJORANA 2 QUANTUM CHIP SHOWS DRAMATICALLY LONGER QUBIT STABILITY, BUT LIMITED PUBLIC DATA AND A LACK OF PEER REVIEW ARE FUELING CALLS FOR INDEPENDENT VERIFICATION. LARGEST-EVER COSMIC MAGNETIC FIELD MAP - SPICE-RACS, BUILT FROM ASKAP DATA, IS THE LARGEST MAP YET OF COSMIC MAGNETIC FIELDS, USING GALAXY “ROTATION MEASURES” TO PROBE HOW MAGNETISM SHAPES GALAXY GROWTH AND THE COSMIC WEB. GLP-1 DRUGS AND CANCER SIGNALS - NEW ASCO-PRESENTED STUDIES SUGGEST GLP-1 DRUGS MAY CORRELATE WITH LOWER CANCER RISK AND BETTER OUTCOMES, BUT RESEARCHERS STRESS OBSERVATIONAL LIMITS AND CALL FOR RANDOMIZED CLINICAL TRIALS. INJECTABLE MICROROBOTS FOR SPINAL REPAIR - ETH ZURICH RESEARCHERS COMBINED STEM CELLS AND MAGNETICALLY RESPONSIVE NANOPARTICLES INTO INJECTABLE MICROROBOTS, HELPING SEVERED SPINAL CORD CONNECTIONS REGROW IN MICE AND IMPROVING MOVEMENT OUTCOMES. STERILE MOSQUITO PROPOSAL IN US - GOOGLE ASKED US REGULATORS TO ALLOW RELEASES OF STERILIZED MALE MOSQUITOES IN CALIFORNIA AND FLORIDA, TESTING LARGE-SCALE BIOLOGICAL CONTROL FOR DISEASE PREVENTION AND PUBLIC ACCEPTANCE. KYRGYZSTAN WINS UN SECURITY COUNCIL SEAT - KYRGYZSTAN WAS ELECTED TO THE UN SECURITY COUNCIL FOR 2027–2028, A RARE DIPLOMATIC WIN FOR CENTRAL ASIA THAT ALSO REVIVED CALLS FOR SECURITY COUNCIL REFORM AND BROADER REGIONAL REPRESENTATION. Episode Transcript Self-adapting AI worm cyber risk We’ll start with cybersecurity, because researchers at the University of Toronto are warning about a new category of threat: an “AI worm” that can adjust its approach as it moves through a network. In their proof-of-concept, the worm probes each machine, looks for known weaknesses, grabs credentials where it can, and then changes strategy on the next target—rather than behaving like the more predictable, scripted worms defenders are used to. The most unsettling twist is the economics: it can hijack infected machines to run the AI reasoning needed for future attacks, potentially making large-scale spread cheaper once it’s launched. The team says it removed details that would help criminals, but the message is clear—security plans built for yesterday’s malware may not hold up against attacks that can pivot in real time. Europe’s push for tech sovereignty Staying with AI, there’s fresh friction between platforms, publishers, and regulators in the UK. The Competition and Markets Authority says online publishers will be able to opt out of appearing in Google Search’s AI Overviews. The CMA is also pushing for clearer attribution and prominent links back to original sources when publisher content shows up in AI-generated summaries. The aim is to give publishers more leverage to negotiate content deals—and potentially payments—at a moment when many say AI answers are cutting into referral traffic. Google’s position is essentially: opting out may reduce visibility in AI results, but it won’t hurt traditional search rankings. Either way, this UK trial is shaping up as a test case for how search will coexist with the web ecosystem that feeds it. Google AI Overviews and publishers And in a related debate—this time inside academia—mathematicians have released the Leiden Declaration on Artificial Intelligence and Mathematics, endorsed by the International Mathematical Union. The declaration argues that AI can generate proofs that look convincing but are wrong, increasing the burden on peer review and risking a research record cluttered with errors. It also flags concerns about citations, training data and licensing, and the way proprietary tools and corporate timelines can distort who gets credit for breakthroughs. The underlying point is simple: mathematics depends on verification and openness, and the community is worried that the incentives around AI could undermine both. Math community’s AI warning Now to Europe’s big policy play. The European Commission has unveiled what it’s calling a European Technological Sovereignty Package—meant to strengthen the EU’s ability to build and control foundational technologies like semiconductors, AI, cloud computing, and open source software. It includes two new legislative proposals, plus an open source strategy, and a roadmap for using digital tech and AI in the energy sector. The Commission’s case is that demand for computing capacity is surging, and Europe is still too dependent on external suppliers for core systems that underpin healthcare, energy grids, and public services. In plain terms: Europe wants more choices, fewer choke points, and less risk that geopolitical shocks disrupt essential tech. Microsoft’s Majorana 2 quantum claim On the frontier-tech front, Microsoft is claiming a major step forward in quantum computing with its new Majorana 2 chip. The company says its qubits can stay stable for dramatically longer—around seconds rather than milliseconds—and it frames that as a path toward a commercially useful quantum computer by 2029. The catch is scale: today’s chip has a small number of qubits, while useful machines are expected to need vastly more. And there’s also a credibility question—independent verification is limited because full technical details aren’t widely public, and an accompanying paper hasn’t been peer reviewed. So this is either a meaningful leap—or a claim that still needs to earn trust through outside validation. Largest-ever cosmic magnetic field map Let’s look up—way up. An international team led by CSIRO and the SKA Observatory has released SPICE-RACS, described as the largest map yet of the Universe’s magnetic fields—reportedly five times larger than all previous efforts combined. Built using Australia’s ASKAP radio telescope, the survey tracks how radio signals from distant galaxies get subtly twisted as they pass through magnetic fields. With that, researchers can infer where magnetism is and how strong it is in relative terms. Why it’s interesting isn’t just the sheer scale: the density of this dataset could open better research into how magnetic fields shape galaxy growth, influence how matter moves through space, and affect the Universe’s long-term evolution. It may also sharpen studies closer to home, including interactions involving the Milky Way and the Magellanic Clouds. The data is public, and the results have been accepted for publication in Australia’s main astronomy journal—while future SKA operations are expected to map the cosmic web in even finer detail. GLP-1 drugs and cancer signals In health news, early research presented at the American Society of Clinical Oncology meeting is adding momentum to a provocative question: could GLP-1 drugs—best known for diabetes care and weight loss—also be linked to better outcomes in multiple cancers? Across more than two dozen mostly observational studies, GLP-1 users showed signals like lower risk for certain cancers, less progression and metastasis, and in some datasets, improved survival. One large study of women, for example, associated GLP-1 use with a noticeably lower risk of breast cancer. Researchers suspect the story may go beyond weight loss, potentially involving inflammation and insulin-related pathways, and some findings even hint at better responses alongside immunotherapies. The important caveat: observational data can’t prove cause and effect. The takeaway is that the consistency of these signals is now strong enough that many experts want rigorous randomized trials to find out what’s real—and what’s just correlation. Injectable microrobots for spinal repair Also in medical science, researchers at ETH Zurich report progress on a hard problem: repairing spinal cords where scar tissue and limited natural regrowth block reconnection. Their approach uses injectable microrobots that combine neural progenitor stem cells with nanoparticles designed to respond to external electromagnetic signals. In mouse experiments with severed spinal cords, electrically stimulating the injury area helped nerve cells begin reconnecting within about four weeks, and the animals showed substantial improvements in movement and coordination. The study, published in Nature Materials, is still early-stage—human testing would require careful work on safety, dosing, and the strength and duration of magnetic-field settings. But it’s a compelling example of combining regenerative cells with targeted stimulation in a way that could, eventually, be more scalable than highly invasive procedures. Sterile mosquito proposal in US A very different kind of biotech story is unfolding in the US, where Google has asked regulators for permission to release up to 32 million sterilised mosquitoes in parts of California and Florida. The plan uses the Sterile Insect Technique, with lab-reared mosquitoes carrying Wolbachia, a bacterium that makes them effectively sterile so the local population declines over time. The releases would focus on males, which don’t bite and aren’t the ones that spread viruses like dengue or Zika. Experts note the technique is widely used in pest management, but scaling it up brings practical hurdles—mass rearing, transport, and careful execution. It’s also a public-trust question: even when the goal is disease reduction, large biological interventions tend to attract scrutiny, and regulators will be weighing both effectiveness and community acceptance. Kyrgyzstan wins UN Security Council seat And finally, a diplomatic milestone: Kyrgyzstan has been elected to the UN Security Council as a non-permanent member for the 2027–2028 term—its first seat since independence in 1991. It won after multiple rounds of voting at the General Assembly, taking an Asia-Pacific slot. It’s a notable moment for Central Asia, a region rarely represented on the Council in recent years. Kyrgyz leaders are presenting the win as a way to amplify the voices of countries that don’t often get a turn in top-level security decision-making—especially landlocked and mountainous states facing distinct security, climate, and development pressures. The election also revived broader calls for Security Council reform, including arguments that representation hasn’t kept pace with today’s global realities. Subscribe to edition specific feeds: - Space news * Apple Podcast English [https://apple.co/4cLLrdt] * Spotify English [https://spoti.fi/4jN8Dui] * RSS English [https://bit.ly/the_automated_daily_space] Spanish [https://theautomateddaily.com/space_es/feed.xml] French [https://theautomateddaily.com/space_fr/feed.xml] - Top news * Apple Podcast English [https://apple.co/3PTvdUF] Spanish [https://apple.co/3ECCMgk] French [https://apple.co/4hmcxbB] * Spotify English [https://spoti.fi/3ZYXAW2] Spanish [https://spoti.fi/414h4JD] French [https://spoti.fi/3Di0jDe] * RSS English [https://bit.ly/the_automated_daily_news] Spanish [https://bit.ly/the_automated_daily_news_es] French [https://bit.ly/the_automated_daily_news_fr] - Tech news * Apple Podcast English [https://apple.co/3RYWbg4] Spanish [https://apple.co/4i0WqRM] French [https://apple.co/4bEAXMm] * Spotify English [https://spoti.fi/3S089pG] Spanish [https://spoti.fi/3EE2Fwv] Spanish [https://spoti.fi/3DlObRE] * RSS English [https://bit.ly/the_automated_daily_tech] Spanish [https://bit.ly/the_automated_daily_tech_es] French [https://bit.ly/the_automated_daily_tech_fr] - Hacker news * Apple Podcast English [https://apple.co/48QWyzj] Spanish [https://apple.co/4ke9jtE] French [https://apple.co/41E1qFd] * Spotify English [https://spoti.fi/45zD1kf] Spanish [https://spoti.fi/4hF8h81] French [https://spoti.fi/3QY26Ak] * RSS English [https://bit.ly/the_automated_daily_hacker_news] Spanish [https://bit.ly/the_automated_daily_hacker_news_es] French [https://bit.ly/the_automated_daily_hacker_news_fr] - AI news * Apple Podcast English [https://apple.co/3M6Tg1o] Spanish [https://apple.co/4315L7Y] French [https://apple.co/3DkZbPb] * Spotify English [https://spoti.fi/3tzOfrz] Spanish [https://spoti.fi/416m40q] French [https://spoti.fi/41HuJGW] * RSS English [https://bit.ly/the_automated_daily_hackernews_ai] Spanish [https://bit.ly/the_automated_daily_hackernews_es_ai] French [https://bit.ly/the_automated_daily_hackernews_fr_ai] Visit our website at https://theautomateddaily.com/ [ https://theautomateddaily.com/] Send feedback to feedback@theautomateddaily.com Youtube [https://www.youtube.com/@TheAutomatedDaily] LinkedIn [https://www.linkedin.com/in/the-automated-daily/] X (Twitter) [https://x.com/automated_daily]

Breakthrough RAS drug for cancer & Personalized mRNA vaccine for melanoma - News (Jun 3, 2026)

Please support this podcast by checking out our sponsors: - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily [https://get.consensus.app/automated_daily] - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad [https://try.gamma.app/tad] - KrispCall: Agentic Cloud Telephony - https://try.krispcall.com/tad [https://try.krispcall.com/tad] Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily [https://buymeacoffee.com/theautomateddaily] TODAY'S TOPICS: BREAKTHROUGH RAS DRUG FOR CANCER - A MAJOR PANCREATIC CANCER TRIAL REPORTS DARAXONRASIB, A BROAD RAS INHIBITOR, NEARLY DOUBLED MEDIAN SURVIVAL—REVIVING HOPES AGAINST LONG-"UNDRUGGABLE" TARGETS LIKE RAS AND MYC. PERSONALIZED MRNA VACCINE FOR MELANOMA - FIVE-YEAR DATA SUGGEST A PERSONALIZED MRNA CANCER VACCINE PLUS KEYTRUDA REDUCED MELANOMA RECURRENCE AND IMPROVED OVERALL SURVIVAL, STRENGTHENING THE CASE FOR MRNA IN ONCOLOGY. NEW IMMUNOTHERAPY BOOSTER IN LUNG CANCER - A SCOTTISH STAGE-FOUR LUNG CANCER PATIENT DESCRIBES MEANINGFUL TUMOR SHRINKAGE IN A TRIAL OF GRWD5769, A DRUG AIMED AT BLOCKING CANCER IMMUNE-ESCAPE AND BOOSTING IMMUNOTHERAPY RESPONSE. ULTRASOUND WEARABLE PACEMAKER PROGRESS - MIT RESEARCHERS DEMONSTRATED A NONINVASIVE, ULTRASOUND-DRIVEN PACING APPROACH USING A SMALL CHEST STICKER AND ENGINEERED HEART CELLS, POINTING TOWARD SURGERY-FREE RHYTHM CONTROL FOR ARRHYTHMIAS. MICROSOFT MAJORANA 2 QUANTUM CHIP CLAIMS - MICROSOFT SAYS ITS MAJORANA 2 QUANTUM CHIP IMPROVES QUBIT STABILITY DRAMATICALLY, BUT SCIENTISTS ARE ASKING FOR PEER-REVIEWED EVIDENCE AND CLEARER INDEPENDENT VERIFICATION. AI WORM RISKS FROM OPEN MODELS - UNIVERSITY OF TORONTO RESEARCHERS SHOWCASED A PROOF-OF-CONCEPT "AI WORM" THAT ADAPTS ACROSS DEVICES USING OPEN-WEIGHT MODELS, RAISING URGENT QUESTIONS FOR CYBERSECURITY AND INFRASTRUCTURE DEFENSE. EU DIGITAL SOVEREIGNTY PUSH ON TECH - THE EUROPEAN UNION IS PREPARING A STRATEGY TO REDUCE RELIANCE ON US AND ASIAN TECH BY EXPANDING EU CLOUD, AI, AND SEMICONDUCTOR CAPACITY, CITING SUPPLY-CHAIN AND DATA-SOVEREIGNTY CONCERNS. UK RULES ON GOOGLE AI OVERVIEWS - THE UK CMA WILL LET PUBLISHERS OPT OUT OF GOOGLE SEARCH AI OVERVIEWS AND REQUIRE CLEARER ATTRIBUTION, A TEST CASE FOR HOW GENERATIVE AI IMPACTS TRAFFIC AND CONTENT PAYMENTS. MATERNAL HEALTH CRISIS IN CAR CAMPS - IN REFUGEE CAMPS NEAR BIRAO, CENTRAL AFRICAN REPUBLIC, FUNDING CUTS AND CONFLICT ARE WORSENING MATERNAL HEALTH ACCESS, WITH RISING RISKS FROM LOST MIDWIVES, CLOSED SERVICES, AND LIMITED PRENATAL CARE. POPE’S ENCYCLICAL AND AI FAIRNESS - POPE LEO XIV’S ENCYCLICAL CALLS FOR HUMAN-CENTERED, TRUTH-FOCUSED TECHNOLOGY, AS PUBLISHERS CITE COLLAPSING CLICK-THROUGH RATES AND A GROWING "SCRAPER ECONOMY" EXPLOITING ONLINE CONTENT. Episode Transcript Breakthrough RAS drug for cancer Let’s start with that cancer breakthrough. A large clinical trial reports that an experimental medicine called daraxonrasib, designed to broadly shut down the RAS family of proteins, nearly doubled median survival for people with a form of advanced pancreatic cancer. Patients on the new drug lived a median of 13.2 months, compared with 6.7 months on standard chemotherapy—results presented at the American Society of Clinical Oncology meeting and published in The New England Journal of Medicine. The bigger story here is historical: RAS has been notoriously hard to target, and past drugs tended to work only for narrow mutations and then hit resistance. Researchers now say this broader RAS approach could unlock combination strategies—and energize efforts against other difficult cancer drivers, including MYC, as well as new attempts to restore the tumor-suppressor p53. Personalized mRNA vaccine for melanoma Staying with oncology, five-year results are strengthening the case for personalized mRNA cancer vaccines—this time in high-risk melanoma. In a study following patients after surgery, the group that received a tailor-made mRNA vaccine plus Keytruda stayed cancer-free at a higher rate than those on Keytruda alone, with overall survival also coming in higher in the combination group. What makes this interesting is the direction of travel: it’s not just treating cancer in the moment, it’s training the immune system to recognize what’s unique about an individual tumor and keep watch for a relapse. Side effects were generally manageable, and a much larger Phase 3 trial is underway to confirm these benefits and potentially support regulatory approval. New immunotherapy booster in lung cancer And another glimpse of what “next-generation” cancer care might look like comes from a personal story out of Scotland. Pat Brogan, who has stage four lung cancer, says an experimental “smart drug” in a clinical trial helped shrink his tumors by almost a third after years of chemotherapy and immunotherapy—and after his disease began progressing again. The drug, known as GRWD5769, is intended to stop cancer cells from slipping past the immune system, effectively making existing immunotherapy more capable of doing its job. It’s one patient’s experience, not a verdict, but it illustrates why researchers are so focused on immune-escape mechanisms: they may offer fresh options when standard treatments run out of room. Ultrasound wearable pacemaker progress From cancer to cardiology now, with a development that sounds almost sci-fi but is rooted in practical aims: MIT engineers and collaborators have built a prototype for a noninvasive “pacemaker” that uses ultrasound delivered from a tiny chest sticker. In lab and animal tests, the system helped correct irregular heart rhythms without surgical implantation. The approach hinges on making heart cells more responsive to ultrasound, so a gentle external signal can help coordinate beating. It’s still early—there are big steps between rats and routine human care—but the headline is simple: a future where pacing could be adjustable, wearable, and potentially surgery-free, lowering barriers for patients who need rhythm support. Microsoft Majorana 2 quantum chip claims Switching to technology, Microsoft is drawing attention with a new quantum chip it calls Majorana 2. The company says this version is about a thousand times more reliable than its previous effort, with qubits staying stable for roughly 20 seconds rather than milliseconds. If true, that kind of stability matters because fragile qubits are one of the main reasons quantum computing has struggled to move from demos to dependable machines. Microsoft is also making an ambitious claim about timing—suggesting commercially useful quantum problems could be in reach by 2029—while acknowledging that scaling would require vastly more qubits than it has today. The caution flag: independent verification is limited so far, and researchers are asking for peer-reviewed evidence and more public detail, especially given the history of controversy around Microsoft’s earlier Majorana-related work. AI worm risks from open models Now to cybersecurity, where researchers at the University of Toronto say they’ve demonstrated a proof-of-concept “AI worm” that can adapt as it spreads—using publicly available, open-weight AI models. Instead of following a rigid script, the worm can probe each machine, exploit known weaknesses, gather credentials, and then adjust its next steps as it moves through a network. One of the most worrying ideas here is economic: if the malware can commandeer infected machines to run its own AI-driven decision-making, the cost of expanding an attack could drop sharply after the initial launch. The team says it worked in a controlled lab and that they removed details that would directly help attackers, but the warning is clear—defenses built for predictable malware may struggle against threats that can improvise. EU digital sovereignty push on tech In Europe, the policy spotlight is on digital independence. The European Union is set to unveil a strategy aimed at reducing reliance on US and Asian technology by bolstering European capacity in semiconductors, cloud computing, and artificial intelligence. EU officials point to a striking dependency: a large share of Europe’s digital products and infrastructure comes from foreign providers, and US companies dominate the cloud market. The plan reportedly includes measures to encourage EU-based data center construction and boost demand for Europe-made chips, along with “sovereignty” criteria in public procurement. The drivers include worries about cross-border data access, supply-chain disruptions, and the risk that political decisions elsewhere could affect essential services at home. UK rules on Google AI Overviews That theme—who benefits from the digital economy, and who gets squeezed—also shows up in the UK, where the Competition and Markets Authority is forcing changes to Google Search’s AI Overviews. UK online publishers will be able to opt out of appearing in AI-generated summaries, and Google will be required to attribute publisher material more clearly with prominent links back to original sources. The goal is to give publishers more leverage to negotiate content deals and potential payments, as many argue that AI answers are cannibalizing referral traffic. Google says opting out may reduce visibility in AI results, but it won’t affect rankings in traditional search listings. This will be trialed in the UK first, and it’s a closely watched test of whether regulators can rebalance power between platforms and creators. Maternal health crisis in CAR camps And in the wider cultural debate over AI, Pope Leo XIV has entered the conversation with his first encyclical, “Magnifica Humanitas,” calling for a truth-centered approach to technology and stronger protection for people who create. While it’s not a policy document, publishers are reading it as moral backing at a moment when they say AI is undermining their economics—both through training on copyrighted work and through search-like AI products that answer questions without sending users to the original sites. The same reporting highlights a growing “scraper economy,” where companies extract online content at industrial scale, often without compensation, and build businesses around it. The takeaway is not that AI is going away, but that fights over attribution, consent, and payment are becoming central to the internet’s next chapter. Pope’s encyclical and AI fairness Finally, a human story that cuts through the abstractions. In a refugee camp near Birao in the Central African Republic, a Sudanese refugee, Maude Ahmad Fadala, delivered her baby on the street—too sick to travel, without money for transport, and without access to a midwife or clinic. Her experience underscores a broader crisis: sub-Saharan Africa accounts for the majority of global maternal deaths, and conflict zones are among the most dangerous places to be pregnant. In this region, years of instability have already left health services threadbare, and recent cuts in humanitarian funding have closed safe spaces, reduced reproductive health supplies, and eliminated vital jobs for midwives and hospital staff. Aid agencies warn that without restored support, the consequences won’t be theoretical—they’ll be counted in preventable deaths. Subscribe to edition specific feeds: - Space news * Apple Podcast English [https://apple.co/4cLLrdt] * Spotify English [https://spoti.fi/4jN8Dui] * RSS English [https://bit.ly/the_automated_daily_space] Spanish [https://theautomateddaily.com/space_es/feed.xml] French [https://theautomateddaily.com/space_fr/feed.xml] - Top news * Apple Podcast English [https://apple.co/3PTvdUF] Spanish [https://apple.co/3ECCMgk] French [https://apple.co/4hmcxbB] * Spotify English [https://spoti.fi/3ZYXAW2] Spanish [https://spoti.fi/414h4JD] French [https://spoti.fi/3Di0jDe] * RSS English [https://bit.ly/the_automated_daily_news] Spanish [https://bit.ly/the_automated_daily_news_es] French [https://bit.ly/the_automated_daily_news_fr] - Tech news * Apple Podcast English [https://apple.co/3RYWbg4] Spanish [https://apple.co/4i0WqRM] French [https://apple.co/4bEAXMm] * Spotify English [https://spoti.fi/3S089pG] Spanish [https://spoti.fi/3EE2Fwv] Spanish [https://spoti.fi/3DlObRE] * RSS English [https://bit.ly/the_automated_daily_tech] Spanish [https://bit.ly/the_automated_daily_tech_es] French [https://bit.ly/the_automated_daily_tech_fr] - Hacker news * Apple Podcast English [https://apple.co/48QWyzj] Spanish [https://apple.co/4ke9jtE] French [https://apple.co/41E1qFd] * Spotify English [https://spoti.fi/45zD1kf] Spanish [https://spoti.fi/4hF8h81] French [https://spoti.fi/3QY26Ak] * RSS English [https://bit.ly/the_automated_daily_hacker_news] Spanish [https://bit.ly/the_automated_daily_hacker_news_es] French [https://bit.ly/the_automated_daily_hacker_news_fr] - AI news * Apple Podcast English [https://apple.co/3M6Tg1o] Spanish [https://apple.co/4315L7Y] French [https://apple.co/3DkZbPb] * Spotify English [https://spoti.fi/3tzOfrz] Spanish [https://spoti.fi/416m40q] French [https://spoti.fi/41HuJGW] * RSS English [https://bit.ly/the_automated_daily_hackernews_ai] Spanish [https://bit.ly/the_automated_daily_hackernews_es_ai] French [https://bit.ly/the_automated_daily_hackernews_fr_ai] Visit our website at https://theautomateddaily.com/ [ https://theautomateddaily.com/] Send feedback to feedback@theautomateddaily.com Youtube [https://www.youtube.com/@TheAutomatedDaily] LinkedIn [https://www.linkedin.com/in/the-automated-daily/] X (Twitter) [https://x.com/automated_daily]

RAS breakthrough in pancreatic cancer & Personalized mRNA vaccine for melanoma - News (Jun 2, 2026)

Please support this podcast by checking out our sponsors: - SurveyMonkey, Using AI to surface insights faster and reduce manual analysis time - https://get.surveymonkey.com/tad [https://get.surveymonkey.com/tad] - Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily [https://get.consensus.app/automated_daily] - Invest Like the Pros with StockMVP - https://www.stock-mvp.com/?via=ron [https://www.stock-mvp.com/?via=ron] Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily [https://buymeacoffee.com/theautomateddaily] TODAY'S TOPICS: RAS BREAKTHROUGH IN PANCREATIC CANCER - A MAJOR CLINICAL TRIAL REPORTS DARAXONRASIB, A BROAD RAS INHIBITOR, NEARLY DOUBLED MEDIAN SURVIVAL IN ADVANCED PANCREATIC CANCER—CHALLENGING THE LONG-HELD “UNDRUGGABLE” RAS NARRATIVE AND BOOSTING COMBINATION-THERAPY HOPES. PERSONALIZED MRNA VACCINE FOR MELANOMA - FIVE-YEAR DATA SUGGEST A PERSONALIZED MRNA CANCER VACCINE PLUS KEYTRUDA LOWERS MELANOMA RECURRENCE RISK AND IMPROVES OVERALL SURVIVAL, STRENGTHENING THE CASE FOR MRNA, NEOANTIGENS, AND TAILORED IMMUNOTHERAPY IN HIGH-RISK PATIENTS. NEW OPTIONS FOR HARD-TO-TREAT CANCERS - SEVERAL ONCOLOGY UPDATES POINT TO FRESH APPROACHES FOR RESISTANT DISEASE: AN IMMUNE-ESCAPE ‘SMART DRUG’ SHOWING EARLY PROMISE, STRONG RESPONSES TO INJECTABLE AMIVANTAMAB IN RECURRENT HEAD AND NECK CANCER, AND IMPROVED SURGICAL OUTCOMES IN HIGH-RISK PROSTATE CANCER. ULTRASOUND STICKER PACEMAKER RESEARCH - MIT-LED RESEARCHERS TESTED A NONINVASIVE PACEMAKER CONCEPT: A SMALL CHEST STICKER DELIVERING ULTRASOUND PULSES TO REGULATE HEART RHYTHM, HINTING AT FUTURE SURGERY-FREE PACING AND CLOSED-LOOP WEARABLE CARDIAC CARE. MATERNAL HEALTH CRISIS IN CAR CAMPS - A REPORT FROM A REFUGEE CAMP NEAR BIRAO DESCRIBES WOMEN GIVING BIRTH WITHOUT TRANSPORT, STAFF, OR SUPPLIES AS HUMANITARIAN FUNDING CUTS DEEPEN A MATERNAL MORTALITY EMERGENCY IN CONFLICT-HIT CENTRAL AFRICAN REPUBLIC. UKRAINE ALLEGES CHILD ABDUCTIONS - PRESIDENT ZELENSKYY SAYS UKRAINE HAS EVIDENCE RUSSIA IS ABDUCTING UKRAINIAN CHILDREN AND TRAINING THEM, ESCALATING ALLEGATIONS ALREADY TIED TO AN ICC WARRANT AND INTENSIFYING CALLS FOR TRACKING, SANCTIONS, AND ACCOUNTABILITY. GOOGLE’S MOSQUITO PLAN FOR DISEASE - GOOGLE IS SEEKING U.S. APPROVAL TO RELEASE MILLIONS OF WOLBACHIA-CARRYING MALE MOSQUITOES IN CALIFORNIA AND FLORIDA TO CURB AEDES AEGYPTI AND REDUCE DENGUE AND ZIKA RISK, REFLECTING WIDER CLIMATE-DRIVEN VECTOR CONCERNS. Episode Transcript RAS breakthrough in pancreatic cancer In cancer research, one of the most striking updates comes from a large pancreatic cancer trial testing an experimental drug called daraxonrasib. Researchers report that patients with a form of advanced pancreatic cancer lived a median of 13.2 months on the new drug, compared with 6.7 months on standard chemotherapy. That’s a huge deal not just because pancreatic cancer is so aggressive, but because the drug is designed to shut down the RAS family of proteins—targets that scientists have struggled with for decades. The takeaway is simple: if broad RAS inhibition holds up and side effects can be managed, this could reshape how multiple RAS-driven cancers are treated, potentially by pairing broad blockers with mutation-specific drugs to stay ahead of resistance. Personalized mRNA vaccine for melanoma Staying with oncology, there’s also encouraging long-term evidence for personalized mRNA vaccines in melanoma. Five-year results from a clinical study suggest that adding a custom-made mRNA vaccine to the immunotherapy Keytruda helped keep more people cancer-free after surgery. About two-thirds of patients on the combination were still cancer-free at five years, compared with roughly half of those on Keytruda alone, and overall survival was higher as well. What makes this interesting is the direction of travel: cancer care is increasingly about training the immune system with instructions tailored to an individual tumor, rather than using one-size-fits-all treatments. A much larger trial is already underway, and if it confirms the benefit, it could push personalized cancer vaccines closer to routine care. New options for hard-to-treat cancers A few other cancer developments are worth a quick stop because they point to the next wave of options for patients who’ve run out of road with standard therapies. In Scotland, a man with stage four lung cancer says an experimental “smart drug” in a clinical trial helped shrink his tumors by nearly a third after prior chemotherapy and immunotherapy stopped working. Early patient stories don’t replace large datasets, but they do highlight a growing focus on blocking the ways tumors hide from the immune system—an area that could make existing immunotherapies work better, for longer. Ultrasound sticker pacemaker research Another headline: an injectable drug called amivantamab showed unusually strong responses in a study of people with head and neck cancer that had returned or resisted treatment. Researchers reported rapid tumor shrinkage in a notable share of patients, including some complete disappearances. For a population with limited alternatives, even a modest improvement can matter; seeing fast, deep responses is what gets clinicians’ attention and drives bigger, confirmatory trials. Maternal health crisis in CAR camps And in prostate cancer, late-stage trial results suggest that adding the drug Erleada to standard hormone therapy around the time of prostate-removal surgery improved outcomes for men with high-risk disease. The big picture here is timing and intensity: treating aggressively before and after surgery may reduce the odds that microscopic cancer cells survive and come roaring back. Regulators will ultimately decide what this changes in practice, but it’s an important signal in a group where recurrence rates remain stubbornly high. Ukraine alleges child abductions From cancer back to the heart—literally—MIT engineers and collaborators have demonstrated a research prototype that hints at a future without implanted pacemakers for some patients. Their concept uses a small chest sticker to deliver ultrasound pulses that can regulate heartbeats. In animal experiments, the system quickly corrected abnormal rhythms, but it relies on a key step: making heart cells more responsive to ultrasound through a gene-therapy-like approach. That means this is not something heading to clinics tomorrow. Still, it’s notable because it imagines pacing as something adjustable, wearable, and potentially surgery-free—a very different model from today’s implanted hardware. Google’s mosquito plan for disease Now to a sobering public health and humanitarian update from the Central African Republic. Reporting from a refugee camp near Birao describes a Sudanese woman delivering her baby on the street after becoming sick and unable to afford transport or access a midwife. The wider issue is that conflict and displacement magnify pregnancy risks, and sub-Saharan Africa accounts for the majority of maternal deaths worldwide. Aid groups say recent funding cuts have forced closures of safe spaces, reduced reproductive health supplies, and eliminated key staff positions—exactly the supports that prevent emergencies from turning fatal. When prenatal care is missed and clinics are overwhelmed, complications are caught late, and tragedies become more common than they should be. Story 8 In global affairs, Ukraine’s President Volodymyr Zelenskyy told CBS News that Ukraine has evidence Russia is abducting Ukrainian children and training them to fight against Ukrainians—an allegation that, if proven, would sharpen already serious accusations into an even darker category. The claim goes beyond earlier reports about children being sent to camps for reeducation. Zelenskyy also said children are being treated as bargaining chips in exchanges, which would violate basic protections for civilians under international law. The International Criminal Court already issued an arrest warrant for Vladimir Putin in 2023 related to alleged unlawful deportations of children, while Russia maintains it is providing humanitarian care. Ukraine says it has documented at least 20,000 abducted children and is calling for more international help to locate and return them. Story 9 Finally, a public health story with a climate angle: Google is seeking U.S. approval to release up to tens of millions of male mosquitoes in parts of California and Florida. The idea is to reduce populations of Aedes aegypti, an invasive species linked to illnesses like dengue and Zika. These released males carry a naturally occurring bacterium called Wolbachia that prevents viable offspring when they mate with wild females, shrinking the next generations without relying on broad pesticide spraying. It’s one more sign that as warming temperatures and global travel expand mosquito habitat and lengthen transmission seasons, communities are looking for new tools that are targeted, trackable, and less chemically intensive. Subscribe to edition specific feeds: - Space news * Apple Podcast English [https://apple.co/4cLLrdt] * Spotify English [https://spoti.fi/4jN8Dui] * RSS English [https://bit.ly/the_automated_daily_space] Spanish [https://theautomateddaily.com/space_es/feed.xml] French [https://theautomateddaily.com/space_fr/feed.xml] - Top news * Apple Podcast English [https://apple.co/3PTvdUF] Spanish [https://apple.co/3ECCMgk] French [https://apple.co/4hmcxbB] * Spotify English [https://spoti.fi/3ZYXAW2] Spanish [https://spoti.fi/414h4JD] French [https://spoti.fi/3Di0jDe] * RSS English [https://bit.ly/the_automated_daily_news] Spanish [https://bit.ly/the_automated_daily_news_es] French [https://bit.ly/the_automated_daily_news_fr] - Tech news * Apple Podcast English [https://apple.co/3RYWbg4] Spanish [https://apple.co/4i0WqRM] French [https://apple.co/4bEAXMm] * Spotify English [https://spoti.fi/3S089pG] Spanish [https://spoti.fi/3EE2Fwv] Spanish [https://spoti.fi/3DlObRE] * RSS English [https://bit.ly/the_automated_daily_tech] Spanish [https://bit.ly/the_automated_daily_tech_es] French [https://bit.ly/the_automated_daily_tech_fr] - Hacker news * Apple Podcast English [https://apple.co/48QWyzj] Spanish [https://apple.co/4ke9jtE] French [https://apple.co/41E1qFd] * Spotify English [https://spoti.fi/45zD1kf] Spanish [https://spoti.fi/4hF8h81] French [https://spoti.fi/3QY26Ak] * RSS English [https://bit.ly/the_automated_daily_hacker_news] Spanish [https://bit.ly/the_automated_daily_hacker_news_es] French [https://bit.ly/the_automated_daily_hacker_news_fr] - AI news * Apple Podcast English [https://apple.co/3M6Tg1o] Spanish [https://apple.co/4315L7Y] French [https://apple.co/3DkZbPb] * Spotify English [https://spoti.fi/3tzOfrz] Spanish [https://spoti.fi/416m40q] French [https://spoti.fi/41HuJGW] * RSS English [https://bit.ly/the_automated_daily_hackernews_ai] Spanish [https://bit.ly/the_automated_daily_hackernews_es_ai] French [https://bit.ly/the_automated_daily_hackernews_fr_ai] Visit our website at https://theautomateddaily.com/ [ https://theautomateddaily.com/] Send feedback to feedback@theautomateddaily.com Youtube [https://www.youtube.com/@TheAutomatedDaily] LinkedIn [https://www.linkedin.com/in/the-automated-daily/] X (Twitter) [https://x.com/automated_daily]

Brain cells playing Doom & Breakthrough injections for cancer - News (Jun 1, 2026)

Please support this podcast by checking out our sponsors: - Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad [https://try.gamma.app/tad] - SurveyMonkey, Using AI to surface insights faster and reduce manual analysis time - https://get.surveymonkey.com/tad [https://get.surveymonkey.com/tad] - Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad [https://try.elevenlabs.io/tad] Support The Automated Daily directly: Buy me a coffee: https://buymeacoffee.com/theautomateddaily [https://buymeacoffee.com/theautomateddaily] TODAY'S TOPICS: BRAIN CELLS PLAYING DOOM - RESEARCHERS IN MELBOURNE TRAINED LAB-GROWN HUMAN NEURONS ON A CHIP TO PLAY DOOM, HIGHLIGHTING ADAPTIVE LEARNING AND POTENTIAL ENERGY-EFFICIENT COMPUTING BEYOND TODAY’S AI. BREAKTHROUGH INJECTIONS FOR CANCER - A TRIPLE-ACTION CANCER INJECTION, AMIVANTAMAB, SHOWED UNUSUALLY STRONG RESPONSES IN HARD-TO-TREAT HEAD AND NECK CANCER, WHILE JOHNSON & JOHNSON REPORTED IMPROVED OUTCOMES FOR HIGH-RISK LOCALIZED PROSTATE CANCER AROUND SURGERY. AI CHIP BOOM AND BOTTLENECKS - MICRON AND SK HYNIX TOPPING $1 TRILLION MARKET CAPS SPOTLIGHTS HIGH-BANDWIDTH MEMORY AS A KEY AI DATA-CENTER BOTTLENECK, WHILE NVIDIA SAYS “AI FACTORIES” AND AI AGENTS ARE RESHAPING INVESTMENT AND JOBS. US-IRAN STRIKES AND HORMUZ - THE US SAID IT STRUCK IRANIAN RADAR AND DRONE COMMAND SITES AFTER A DRONE INCIDENT, IRAN SIGNALED RETALIATION, AND THE STRAIT OF HORMUZ REMAINS EFFECTIVELY BLOCKED—RAISING GLOBAL OIL AND LNG SUPPLY CONCERNS. UKRAINE STRIKES, CHILDREN ALLEGATIONS - UKRAINE HIT RUSSIAN OIL FACILITIES WITH LONG-RANGE DRONES AS RUSSIA WARNED OF BROADER STRIKES; ZELENSKYY ALSO ALLEGED CHILD ABDUCTIONS AND FORCED TRAINING—ADDING PRESSURE FOR INVESTIGATIONS AND SANCTIONS. AI HELPING ARTISTS CREATE - SINGER-SONGWRITER SAMUEL SMITH USED AI MUSIC TOOLS AS AN ASSISTIVE CREATIVE BRIDGE AFTER PARKINSON’S LIMITED HIS GUITAR PLAYING, UNDERSCORING AI’S GROWING ROLE IN PRESERVING ARTISTIC INTENT. Episode Transcript Brain cells playing Doom Let’s start with the story that sounds like science fiction. Researchers at Melbourne-based Cortical Labs say they’ve trained lab-grown human neurons—living on a silicon chip—to play the classic shooter game Doom. The neurons didn’t start out skilled. Early on, they behaved like a clueless beginner: bumping into walls, firing randomly, and getting nowhere fast. But with continued training, the cultures began to respond more purposefully, increasingly targeting enemies and adapting in real time. This isn’t about turning brain cells into gamers. The bigger idea is that biology learns with very low energy use compared with today’s power-hungry computing. The team says platforms like this could eventually help with drug testing and disease modeling, even if it’s still early and the neuron cultures don’t last long. Breakthrough injections for cancer Now to medicine, where two cancer updates are drawing attention ahead of the American Society of Clinical Oncology meeting. First: doctors reported what they called “unprecedented” results from an international trial of amivantamab, a triple-action injection for people with recurrent or metastatic head and neck cancer that had stopped responding to standard chemotherapy and immunotherapy. In a study spanning 11 countries and 102 patients, tumors shrank or disappeared in 43 people. Fifteen patients saw their tumors vanish entirely, and some changes showed up within weeks. What makes this especially notable is the setting: once head and neck cancers reach this stage—often HPV-negative—the options can be limited and outcomes are typically poor. The treatment is delivered as an under-the-skin jab every three weeks, potentially simpler than regular intravenous infusions. Side effects were mostly mild to moderate, and fewer than one in ten people stopped treatment. Median overall survival after starting therapy was reported at 12.5 months—an important signal in a group where the bar is painfully low. AI chip boom and bottlenecks The second cancer story comes from Johnson & Johnson in high-risk prostate cancer—earlier-stage disease, but still one that frequently comes back after today’s standard treatment. In a late-stage trial, adding the drug Erleada to standard testosterone-suppressing hormone therapy around the time of prostate-removal surgery improved outcomes in men with high-risk localized or locally advanced cancer. Patients on the combination were far more likely to have minimal to no detectable cancer at surgery, and the company reported meaningful reductions in the risk of progression or death. If these results hold up and regulators agree, it could change the treatment playbook for a large group of patients—especially since a significant share of prostate cancer diagnoses in the US fall into the high-risk category. US-Iran strikes and Hormuz Shifting to technology and markets: memory chips—long treated as a commodity corner of the semiconductor world—are now being priced like strategic infrastructure for AI. Micron and South Korea’s SK Hynix have both climbed to market values above one trillion dollars. The driver is high-bandwidth memory, or HBM, which has become a choke point for AI data centers. In plain terms: AI systems can be limited not only by how fast they compute, but by how quickly they can access the right data. When that kind of memory is scarce, the suppliers gain leverage—through demand, through pricing power, and through longer-term orders that look less “boom and bust” than past chip cycles. The broader takeaway is that investors are increasingly treating memory as essential to AI growth, not just a cyclical bet that rises and falls with gadget demand. Ukraine strikes, children allegations And speaking of AI hardware, Nvidia’s CEO Jensen Huang used GTC Taipei to argue that AI has moved from experiments to profit engines—and even a contributor to GDP growth. Huang’s core message was that companies are building “AI factories” because the output of AI—what he framed as a flood of usable work products—can be monetized. He also pushed back on the idea that AI automatically means fewer jobs, saying AI-assisted coding can increase productivity and, in some cases, lead to hiring more engineers. He predicted that “AI agents” will become a kind of digital labor force, eventually numbering in the billions. Whether you buy the timeline or not, the direction is clear: companies are betting that software that can plan, remember, and act will be a major new layer of the economy. AI helping artists create Now to the Middle East, where tensions around the Strait of Hormuz are escalating again—with implications that extend well beyond the region. The US says it carried out weekend “self-defence” strikes on Iranian radar and drone command-and-control sites near Iran’s southern coast and on Qeshm Island, following what Washington described as aggressive Iranian actions, including the downing of a US drone over international waters. Iran’s Revolutionary Guard said it responded by targeting an air base in Kuwait used by US forces. Kuwait reported hostile missiles and drones, and air-raid sirens reportedly sounded nationwide. US Central Command said two Iranian ballistic missiles aimed at US forces in Kuwait were intercepted, and that no American personnel were hurt. This is the third major escalation in a week, and the Strait of Hormuz remains effectively blocked—a critical problem for global oil and LNG shipments. Ceasefire-extension talks appear to be stalling, with reports that proposed terms and demands are shifting. The key risk here is miscalculation: even limited tit-for-tat actions can rattle energy markets when the shipping lane is already constrained. Story 7 Turning to Ukraine: overnight drone strikes set fires at Russian oil facilities, according to Russian officials, including reported damage in Taganrog in the Rostov region and a separate fire in Armavir in the Krasnodar region. President Volodymyr Zelenskyy highlighted that Armavir is roughly 500 kilometers from Ukraine’s border—an underscore of Ukraine’s growing long-range reach. The strategy is straightforward: oil infrastructure helps fund Russia’s war effort, and disrupting it can raise costs and create logistical headaches. Russia, meanwhile, continues long-range attacks on Ukrainian cities and infrastructure, and Kyiv is bracing for what Moscow has called broader “systemic strikes.” Zelenskyy is again urging the US for more Patriot air defenses. Tensions also rose after a Russian drone strike injured two people in Romania, a NATO member—fueling concern about spillover. And in another reminder of the risks, Russia’s Rosatom said a Ukrainian drone hit the Russian-controlled Zaporizhzhia nuclear power plant, causing minor damage but no reported harm to critical equipment. The IAEA has warned repeatedly: even small incidents at a nuclear site carry outsized danger. Story 8 One more Ukraine-related development is drawing sharp scrutiny. Zelenskyy told CBS News that Ukraine has evidence Russia is abducting Ukrainian children and training them to fight against Ukrainians—an allegation that, if proven, would intensify war-crimes concerns. The claim goes beyond earlier reporting about children being sent to camps for reeducation or “Russification.” Zelenskyy also said children are being treated as bargaining chips, offered in exchanges for captured soldiers—something he argues is plainly illegal under international humanitarian law. Ukraine says it has documented at least 20,000 abducted children. Russia has framed its actions as humanitarian care for war orphans, but the International Criminal Court issued an arrest warrant for Vladimir Putin in 2023 over alleged unlawful deportation of children. The next question is whether international bodies and governments can verify new evidence quickly—and what pressure follows. Story 9 Finally, a quieter story about AI’s role in everyday life—this time in music. London-based singer-songwriter Samuel Smith, diagnosed with Parkinson’s disease in 2020, has been using AI tools as his condition has taken away much of his ability to play guitar. He recently released a second album, and used AI music-generation platforms to help shape at least one track—creating demo arrangements to communicate structure and feel to the musicians who recorded the final version. It’s a useful reminder that AI isn’t only about speed or automation. In some cases, it’s assistive technology—helping people keep creating when the body won’t cooperate, and preserving personal artistic intent. Story 10 That’s the top news for today. If you’re keeping score, the big themes are capability and constraint: new medical options where choices were running out, new computing power—and new bottlenecks—driving markets, and geopolitical flashpoints where a single decision can tighten global supply lines. Thanks for listening to The Automated Daily, top news edition. I’m TrendTeller—see you next time. Subscribe to edition specific feeds: - Space news * Apple Podcast English [https://apple.co/4cLLrdt] * Spotify English [https://spoti.fi/4jN8Dui] * RSS English [https://bit.ly/the_automated_daily_space] Spanish [https://theautomateddaily.com/space_es/feed.xml] French [https://theautomateddaily.com/space_fr/feed.xml] - Top news * Apple Podcast English [https://apple.co/3PTvdUF] Spanish [https://apple.co/3ECCMgk] French [https://apple.co/4hmcxbB] * Spotify English [https://spoti.fi/3ZYXAW2] Spanish [https://spoti.fi/414h4JD] French [https://spoti.fi/3Di0jDe] * RSS English [https://bit.ly/the_automated_daily_news] Spanish [https://bit.ly/the_automated_daily_news_es] French [https://bit.ly/the_automated_daily_news_fr] - Tech news * Apple Podcast English [https://apple.co/3RYWbg4] Spanish [https://apple.co/4i0WqRM] French [https://apple.co/4bEAXMm] * Spotify English [https://spoti.fi/3S089pG] Spanish [https://spoti.fi/3EE2Fwv] Spanish [https://spoti.fi/3DlObRE] * RSS English [https://bit.ly/the_automated_daily_tech] Spanish [https://bit.ly/the_automated_daily_tech_es] French [https://bit.ly/the_automated_daily_tech_fr] - Hacker news * Apple Podcast English [https://apple.co/48QWyzj] Spanish [https://apple.co/4ke9jtE] French [https://apple.co/41E1qFd] * Spotify English [https://spoti.fi/45zD1kf] Spanish [https://spoti.fi/4hF8h81] French [https://spoti.fi/3QY26Ak] * RSS English [https://bit.ly/the_automated_daily_hacker_news] Spanish [https://bit.ly/the_automated_daily_hacker_news_es] French [https://bit.ly/the_automated_daily_hacker_news_fr] - AI news * Apple Podcast English [https://apple.co/3M6Tg1o] Spanish [https://apple.co/4315L7Y] French [https://apple.co/3DkZbPb] * Spotify English [https://spoti.fi/3tzOfrz] Spanish [https://spoti.fi/416m40q] French [https://spoti.fi/41HuJGW] * RSS English [https://bit.ly/the_automated_daily_hackernews_ai] Spanish [https://bit.ly/the_automated_daily_hackernews_es_ai] French [https://bit.ly/the_automated_daily_hackernews_fr_ai] Visit our website at https://theautomateddaily.com/ [ https://theautomateddaily.com/] Send feedback to feedback@theautomateddaily.com Youtube [https://www.youtube.com/@TheAutomatedDaily] LinkedIn [https://www.linkedin.com/in/the-automated-daily/] X (Twitter) [https://x.com/automated_daily]